Purepharm

What Purepharm does

Purepharm Ltd is a privately held Northern Ireland-based pharmaceutical wholesaler, parallel importer, and exporter operating across the UK and the European Union. Founded in 2015 and registered as company NI633312, the company is headquartered in Loughgall (Co. Armagh) with an MHRA-registered distribution facility at Craigavon's Bluestone Business Park (WDA(H): 45310). The company supplies four interconnected product lines: UK Generics (access to 2000 generic pharmaceutical lines with a specialisation in niche and hard-to-source products), Ethical Products (UK branded pharmaceuticals), Parallel Imports (an in-house portfolio focused on niche and innovative product licenses), and Exports (UK, Irish, and EU pharmaceuticals, including generics, branded medicines, nutritionals, and medical devices). Its customer base ranges from small independent pharmacies to large multinational wholesalers across the UK and EU.

The company's technology stack is anchored by a bespoke IT system providing full traceability of stock from procurement through delivery, and an Omnicell Mach4 Pharmacy Robotics System at the Craigavon facility supporting warehouse automation. Operations are conducted under an MHRA Wholesale Dealer Authorisation and EU Good Distribution Practice (GDP) principles, with all stock verified as genuine, undamaged, and sourced only from registered wholesale dealers or manufacturers, with full audit trails maintained for all pharmaceuticals procured. The company handles both ambient and refrigerated pharmaceuticals and offers a consultancy service on licensing, availability, and pricing across UK, Irish, and EU markets.

Purepharm operates a B2B, sales-led go-to-market model, engaging directly with pharmacies, healthcare providers, and pharmaceutical wholesalers through established trading relationships rather than digital marketing campaigns. Revenue is generated through transaction-based wholesale pricing on pharmaceutical supply, with free next-day delivery on orders over £100 and payment terms of end-of-month following invoice (wholesale on delivery, limited 30 days). The company is privately held with no disclosed funding rounds, parent company, acquisitions, or executive leadership changes in the available data. No revenue figures are publicly disclosed.

Name

Purepharm

Legal name

Purepharm Ltd

Website

https://www.purepharm.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

51–100 employees

Short description

Purepharm is a Northern Ireland-based pharmaceutical wholesaler, parallel importer, and exporter serving UK and EU customers from independent pharmacies to multinational wholesalers with 2000 generic lines, an MHRA-registered facility, and EU GDP-compliant supply chain.

Ownership category

akta.pro rank

Product category

Pharmaceutical Wholesale Distribution

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Full-Line Pharmaceutical Wholesalers (HLAIAJAA)

Keywords

• Pharmaceutical wholesale distribution
• Parallel import pharmaceuticals
• Generic pharmaceutical supply
• Pharmaceutical export services
• EU GDP compliant distribution

Headquarters

HQ city

Loughgall

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Infrastructure, Personnel, Technology or R&D

Revenue model

1. Pharmaceutical Wholesale: Purepharm generates revenue through the wholesale supply of generic and branded pharmaceuticals, parallel imports, and exports. The company supplies products from UK, Ireland and wider EU manufacturers to pharmacies and healthcare providers across Europe.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Purepharm is a pharmaceutical wholesaler, parallel importer and exporter supplying generic, branded and parallel-import pharmaceutical and healthcare products across the UK and EU. The company purchases from UK, Irish and EU manufacturers and delivers to independent pharmacies, healthcare providers and other wholesalers, with a specialisation in niche and hard-to-source generic lines. Operations are anchored by an MHRA registered facility in Northern Ireland operating to EU GDP principles, supported by a bespoke IT system for full traceability.

Product overview

Purepharm is a pharmaceutical wholesaler, parallel importer, and exporter operating as a single integrated product offering. The company provides four interconnected product lines: UK Generics (access to 2000 generic pharmaceutical lines), Ethical Products (UK branded pharmaceuticals), Parallel Imports (own portfolio of PI pharmaceuticals), and Exports (UK, Irish, and EU pharmaceutical exports including generics, branded pharmaceuticals, nutritionals, and medical devices). The product portfolio is supported by an MHRA registered facility, EU GDP compliant supply chain, and bespoke IT system for full traceability.

Differentiator

Problem solved

Functional benefit

Products and services

• UK Generics Wholesale supply of generic pharmaceutical lines — access to 2,000 generic pharmaceutical lines supplied at market-leading prices through close manufacturer relationships. Specialises in procurement and supply of niche and hard-to-source generic products for independent pharmacies and wholesalers across the UK and EU.
• Ethical Products Wholesale supply of UK branded pharmaceuticals sourced from a trusted network of suppliers, delivering a broad portfolio of genuine UK branded medicines cost-effectively to the healthcare sector with quality and reliability as the focus.
• Parallel Imports Own portfolio of parallel import (PI) pharmaceuticals focused on niche and innovative product licenses, delivered to healthcare professionals using a verified European supplier base and manufacturing partners to ensure quality and patient safety.
• Exports Sourcing and export of UK, Irish, and EU pharmaceuticals — including generics, branded pharmaceuticals, nutritionals, and medical devices — with extensive supply chain of EU suppliers operating to EU GDP principles and full audit trails for all pharmaceuticals procured.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Alliance Healthcare: UK and pan-European pharmaceutical wholesaler (part of Walgreens Boots Alliance) supplying generics, branded medicines and parallel imports to pharmacies. Closest direct competitor to Purepharm across the same UK/EU wholesale channels and customer base.
• AAH Pharmaceuticals: Major UK pharmaceutical wholesaler distributing generics, branded medicines and OTC products to independent pharmacies and hospitals. Comparable mid-market competitor with overlapping product lines and independent pharmacy customer base.
• Mawdsleys: UK pharmaceutical wholesaler and parallel importer of branded and generic medicines with a similar mid-market positioning. Directly comparable on PI portfolio focus, generics distribution, and UK-focused customer base.
• Lexon (UK): UK pharmaceutical wholesaler offering generics, branded medicines and parallel imports to pharmacies. Similar scale profile to Purepharm and directly comparable on specialty generics, PI sourcing, and UK independent pharmacy customers.
• Trident Pharmaceuticals: UK pharmaceutical wholesaler supplying generics, branded medicines and parallel imports to pharmacies and healthcare providers. Directly comparable on product mix (generics + PI) and UK-focused customer segments.

Broad incumbents

• Phoenix Group: Pan-European pharmaceutical wholesale leader with significant UK presence under Phoenix Medical. Much larger incumbent operating across the same generics, branded, and parallel import categories as Purepharm, but at significantly greater scale.
• McKesson UK: UK arm of global pharmaceutical distributor McKesson Corporation. Operates broadly in pharmaceutical wholesale and distribution with far greater scale, range and procurement leverage than Purepharm.
• Ethypharm: European specialty pharmaceutical company active in generic and specialty drug distribution across the UK and EU. Comparable on cross-border European pharmaceutical supply and specialty generics, though with broader manufacturing capabilities.

Emerging players

• Smartway Pharmaceuticals: UK-based pharmaceutical wholesaler and parallel importer focused on generics and specialty medicines for UK and EU customers. Comparable mid-market player with overlapping PI sourcing model and similar independent pharmacy customer base.
• Nupharm: UK specialty pharmaceutical company supplying niche generics and hard-to-source medicines across the UK and EU. Comparable on niche-generics focus and parallel-import sourcing model, though at smaller scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/purepharm

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Purepharm